ZELTIQ® Aesthetics Launches New CoolFit Applicator Globally
March 01 2013 - 8:00AM
Business Wire
ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology
company focused on developing and commercializing products
utilizing its proprietary controlled-cooling technology, today
announced the global introduction of CoolFit, the newest addition
to the applicator platform for the CoolSculpting System, at the
American Academy for Dermatology (AAD) annual meeting in Miami.
“We are committed to optimizing patient outcomes and are focused
on providing additional applicators that are both more efficient
and that treat a broader range of patients,” said Mark Foley,
President and Chief Executive Officer of ZELTIQ. “CoolFit’s
configuration and larger treatment area provides physicians with
even more options when assessing patients and developing truly
customized treatment plans to achieve the desired results.”
CoolFit’s advanced engineering design features a flat applicator
cup and 38 percent larger cooling plates than the CoolCore
applicator. This enables treatment of different areas on more body
types than ever before. With CoolFit, it is possible for more
patients to take advantage of CoolSculpting’s unique cooling
approach that selectively targets and destroys fat, something
heat-based procedures cannot replicate.
“The CoolFit design allows me to treat harder to reach areas
and, for the first time, longer fat bulges, which is attracting new
patients to my practice,” said Brian Zelickson, MD, Medical
Director of Zel Skin & Laser Specialists in Edina, Minn. “My
CoolSculpting patients who are being treated with CoolFit are very
satisfied with their individual results.”
The fifth applicator to be introduced for use with
CoolSculpting, the CoolFit applicator allows physicians to easily
customize patients’ treatment plans, particularly in areas with
longer and hard-to-reach fat bulges.
“CoolFit really rounds out the CoolSculpting applicator platform
and has been a welcome addition to my practice because of its
versatility,” said Jay Burns, MD, Medical Director of EpiCentre
Park Lane in Dallas and EpiCentre Legacy in Plano, Texas. “In
combination, all the applicators broaden the scope of treatable
patients and their respective outcomes.”
In the United States and Taiwan, CoolSculpting is cleared for
non-invasive fat reduction in the abdomen and flank. In other
international markets, CoolSculpting is cleared for general
non-invasive fat reduction. More than 500,000 CoolSculpting
treatments have been performed worldwide. CoolSculpting results in
an undeniable reduction of fat in the treated areas, and patients
can start to see results as soon as three weeks following
treatment, with the most dramatic results occurring over a period
of two to four months in most patients. Every patient case is
unique which is why ZELTIQ recommends a customized treatment plan
as part of the initial consultation. After the initial treatment is
complete, patients can attain further reductions with additional
treatments, resulting in even more fat loss.
About CoolSculpting®
CoolSculpting is a non-surgical, clinically proven procedure
designed to selectively reduce fat bulges in problem areas using a
patented cooling technology. Cleared by the FDA for noninvasive fat
reduction in the abdomen and flank, it is a procedure that gently
cools unwanted fat cells in the body to induce a natural,
controlled elimination of fat cells. It is designed to reduce fat
bulges in treated areas of the body without harming surrounding
tissue. CoolSculpting is available through an elite network of
CoolSculpting Centers worldwide. Dermatologists, plastic surgeons
and leading aesthetic specialists that offer CoolSculpting can be
found at www.coolsculpting.com.
Be sure to follow CoolSculpting on Facebook, Twitter and
YouTube.
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ’s first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat bulges that may not respond to diet or
exercise. CoolSculpting is based on the scientific principle that
fat cells are more sensitive to cold than the overlying skin and
surrounding tissues. CoolSculpting utilizes patented technology of
precisely controlled cooling to reduce the temperature of fat cells
in the treated area, which is intended to cause fat cell
elimination through a natural biological process known as
apoptosis, without causing scar tissue or damage to the skin,
nerves, or surrounding tissues. ZELTIQ developed CoolSculpting to
safely, noticeably, and measurably reduce the fat layer within a
treated fat bulge without requiring the patient to diet or
exercise.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024